- Home
- IRBT vs AGEN Comparison
IRBT vs AGEN Comparison
Compare IRBT & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- AGEN
- Stock Information
- Founded
- IRBT 1990
- AGEN 1994
- Country
- IRBT United States
- AGEN United States
- Employees
- IRBT N/A
- AGEN N/A
- Industry
- IRBT Consumer Electronics/Appliances
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRBT Consumer Discretionary
- AGEN Health Care
- Exchange
- IRBT Nasdaq
- AGEN Nasdaq
- Market Cap
- IRBT 99.8M
- AGEN 87.7M
- IPO Year
- IRBT N/A
- AGEN 2000
- Fundamental
- Price
- IRBT $3.17
- AGEN $4.80
- Analyst Decision
- IRBT Hold
- AGEN Buy
- Analyst Count
- IRBT 1
- AGEN 4
- Target Price
- IRBT N/A
- AGEN $13.00
- AVG Volume (30 Days)
- IRBT 3.8M
- AGEN 1.6M
- Earning Date
- IRBT 08-05-2025
- AGEN 08-07-2025
- Dividend Yield
- IRBT N/A
- AGEN N/A
- EPS Growth
- IRBT N/A
- AGEN N/A
- EPS
- IRBT N/A
- AGEN N/A
- Revenue
- IRBT $633,404,000.00
- AGEN $99,524,000.00
- Revenue This Year
- IRBT $3.23
- AGEN $12.69
- Revenue Next Year
- IRBT $28.90
- AGEN N/A
- P/E Ratio
- IRBT N/A
- AGEN N/A
- Revenue Growth
- IRBT N/A
- AGEN N/A
- 52 Week Low
- IRBT $1.76
- AGEN $1.38
- 52 Week High
- IRBT $13.45
- AGEN $18.74
- Technical
- Relative Strength Index (RSI)
- IRBT 48.39
- AGEN 54.50
- Support Level
- IRBT $3.03
- AGEN $4.38
- Resistance Level
- IRBT $3.60
- AGEN $5.20
- Average True Range (ATR)
- IRBT 0.36
- AGEN 0.57
- MACD
- IRBT -0.07
- AGEN -0.10
- Stochastic Oscillator
- IRBT 15.88
- AGEN 43.60
About IRBT iRobot Corporation
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).